SMTL ID : 3fli.1

Discovery of XL335, a Highly Potent, Selective and Orally-Active Agonist of the Farnesoid X Receptor (FXR)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x 33Y: 1-methylethyl 3-[(3,4-difluorophenyl)carbonyl]-1,1-dimethyl-1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate(Non-covalent)

33Y.1: 19 residues within 4Å: Chain A: I.28, T.29, I.32, L.46, T.47, M.49, A.50, H.53, M.87, F.88, R.90, S.91, I.94, F.95, L.107, I.111, M.124, Y.128, M.209 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:I.32, A:L.46, A:L.46, A:A.50, A:F.88, A:R.90, A:I.94, A:I.111, A:Y.128 Hydrogen bonds: A:L.46, A:Y.128 Halogen bonds: A:T.29

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Flatt, B. et al., Discovery of XL335 (WAY-362450), a highly potent, selective, and orally active agonist of the farnesoid X receptor (FXR). J.Med.Chem. (2009)

Release Date

2009-12-22

Peptides

Bile acid receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Bile acid receptor